Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives is a podcast hosted by Drs. Diana Isaacs and Natalie Bellini aimed at providing a regular roundup of the latest clinically applicable insights across diabetes and metabolic diseases, with a focus on leveraging technology to improve care. A video version of each episode is available at HCPLive.com/Clinical/Endocrinology.
Please direct podcast-related inquiries to [email protected].
Editor's note: Episodes predating January 2023 were hosted by Endocrinology Network. Episodes predating March 2022 were titled The Endocrine Outlook.
Please direct podcast-related inquiries to [email protected].
Editor's note: Episodes predating January 2023 were hosted by Endocrinology Network. Episodes predating March 2022 were titled The Endocrine Outlook.
- Update frequency
- every 5 days
- Average duration
- 21 minutes
- Episodes
- 160
- Years Active
- 2020 - 2025
Patient Considerations for Inhaled Insulin, with Carol Levy, MD
In this special edition recorded at the 84th American Diabetes Association Scientific Sessions, Carol Levy, MD, director of the Mount Sinai Diabetes Center and Type 1 Diabetes Clinical Research, join…
00:18:11 |
Thu 18 Jul 2024
ADA 2024 Diabetes Technology Recap
This special edition episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives focuses on top highlights and updates in diabetes technology from the 84th American Diabetes Ass…
00:32:11 |
Thu 18 Jul 2024
June 2024 Updates in Diabetes Technology and T1D
In this episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, provide a June 2024 update focusing on a trio of topic…
00:24:16 |
Mon 17 Jun 2024
GLAM and CRISTAL, Updates in Pregnancy
In this episode, hosts provide their audience with an overview of a pair of new studies on the topic of diabetes in pregnancy: the GLAM and CRISTAL studies.
00:21:09 |
Wed 05 Jun 2024
FLOW Trial and Semaglutide's Benefit in Chronic Kidney Disease
To celebrate the FLOW trial and break down what it means for people with type 2 diabetes and CKD, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, recorded a special edition episode to discuss t…
00:13:32 |
Fri 31 May 2024
2024 ACP Type 2 Diabetes Recommendations
The American College of Physicians has released new recommendations in favor of SGLT2i and GLP-1 RA and against the use of DPP-4i as second-line therapies to metformin in adults with type 2 diabetes …
00:23:31 |
Sat 20 Apr 2024
STEP HFpEF DM and Fair Allocation of Incretin-Based Therapies
In this episode, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, tackle a pair of related topics: what the STEP HFpEF DM trial from ACC.24 means for the diabetes community and the need for fair…
00:23:31 |
Sat 20 Apr 2024
What to Know about Sequel Med Tech's twiist AID System, with Alan Lotvin, MD
The diabetes community welcomed an additional tool to the armamentarium with the US Food and Drug Administration’s clearance of the twiist automated insulin delivery (AID) system on March 18, 2024. C…
00:31:29 |
Sat 30 Mar 2024
Hot Topics and Updates from ATTD 2024
In the third and final recap episode from the 17th annual International Conference on Advanced Technologies & Treatments for Diabetes, hosts of Diabetes Dialogue: Technology, Therapeutics, & Real-Wor…
00:20:40 |
Sat 30 Mar 2024
T1D Glycemic Improvement and CRISTAL at ATTD 2024
In this episode, hosts provide insight from automated insulin delivery updates from the 17th annual International Conference on Advanced Technologies & Treatments for Diabetes. The specific topics of…
00:08:29 |
Tue 26 Mar 2024
FLOW Trial and Chronic Kidney Disease Updates, with Brendon Neuen, MBBS, PhD
In this episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives hosts are joined by Brendon Neuen, MBBS, PhD, nephrologist and director of the Kidney Trials Unit at Royal No…
00:29:52 |
Fri 22 Mar 2024
Dexcom Stelo and CGM Updates, with Jake Leach
Hosts of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives recorded a special edition episode with Jake Leach, chief operating officer of Dexcom. The episode itself represents a …
00:28:26 |
Fri 22 Mar 2024
Tirzepatide and the Future of Incretin Therapies, with Timothy Garvey, MD
W. Timothy Garvey, MD, professor of medicine and director of the Diabetes Research Center at the University of Alabama at Birmingham and the principal investigator of SURMOUNT-2, joins our hosts to p…
00:24:52 |
Mon 18 Mar 2024
SELECT, Semaglutide, & the Future of Incretin Therapies, with A. Michael Lincoff, MD
In this episode, hosts are joined by co-chair of the SELECT steering committee A. Michael Lincoff, MD, to discuss results, potential explanations for cardiovascular benefit of semaglutide 2.4 mg beyo…
00:24:40 |
Sat 02 Mar 2024
Understanding MARD, Comparing Popular CGM Sensors
In this episode, the hosts breakdown a pair of recent publications related to better understanding the strengths and limitations of MARD as well as a study comparing the Dexcom G7 and FreeStyle Libre…
00:21:43 |
Thu 29 Feb 2024
ATTD 2024 Preview
In the episode, hosts provide insight into sessions to watch, device news they are excited for, what makes ATTD a unique and valuable experience for the diabetes care team, and how the meeting’s annu…
00:14:33 |
Mon 26 Feb 2024
Time in Range, CGM Metrics for Predicting Outcomes in Diabetes
The introduction of CGM in 1999 completely shifted the trajectory of care for people with diabetes. Now, new data suggest advanced CGM metrics, such as time in range, are proving comparable to HbA1c …
00:15:14 |
Tue 20 Feb 2024
Tirzepatide in Type 1 Diabetes, with Viral Shah, MD
In this episode, hosts are joined by Shah for a discussion on his recent proof-of-concept study looking at tirzepatide in type 1 diabetes, the prospect of GLP-1 RA-based therapies in type 1 diabetes,…
00:16:43 |
Thu 15 Feb 2024
Diabetes Technology Updates in January 2024
In this episode, hosts discuss recent news and updates in diabetes technology from Abbott, Dexcom, and Medtronic in the first half of January 2024.
Episode Highlights
00:40 Abbott FreeStyle Libre 2…
00:30:19 |
Wed 10 Jan 2024
Updates in Management of Hypercortisolism in Type 2 Diabetes, with Ralph DeFronzo, MD
In this episode, hosts sit down with Ralph DeFronzo, MD, for a discussion on how advances in management have transformed the diagnosis and management of hypercortisolism among people with type 2 diab…
00:31:58 |
Tue 09 Jan 2024
Disclaimer: The podcast and artwork embedded on this page are the property of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives. This content is not affiliated with or endorsed by eachpod.com.